Applied Genetic Technologies Stock Price, News & Analysis (NASDAQ:AGTC)

$3.75 0.00 (0.00 %)
(As of 02/21/2018 02:24 PM ET)
Previous Close$3.75
Today's Range$3.70 - $3.80
52-Week Range$3.25 - $8.40
Volume24,000 shs
Average Volume110,695 shs
Market Capitalization$67.89 million
P/E Ratio-6.25
Dividend YieldN/A
Beta2.03

About Applied Genetic Technologies (NASDAQ:AGTC)

Applied Genetic Technologies logoApplied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).

Receive AGTC News and Ratings via Email

Sign-up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AGTC
CUSIPN/A
Phone386-462-2204

Debt

Debt-to-Equity RatioN/A
Current Ratio6.49%
Quick Ratio6.49%

Price-To-Earnings

Trailing P/E Ratio-6.24989583506941
Forward P/E Ratio-2.88
P/E GrowthN/A

Sales & Book Value

Annual Sales$39.47 million
Price / Sales1.72
Cash Flow$0.07 per share
Price / Cash51.49
Book Value$6.16 per share
Price / Book0.61

Profitability

Trailing EPS($0.60)
Net Income$400,000.00
Net Margins-33.24%
Return on Equity-9.21%
Return on Assets-7.35%

Miscellaneous

Employees72
Outstanding Shares18,100,000

Applied Genetic Technologies (NASDAQ:AGTC) Frequently Asked Questions

What is Applied Genetic Technologies' stock symbol?

Applied Genetic Technologies trades on the NASDAQ under the ticker symbol "AGTC."

How were Applied Genetic Technologies' earnings last quarter?

Applied Genetic Technologies Corp (NASDAQ:AGTC) released its quarterly earnings data on Friday, February, 9th. The biotechnology company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.09) by $0.20. The biotechnology company had revenue of $4.85 million for the quarter, compared to analyst estimates of $8.72 million. Applied Genetic Technologies had a negative net margin of 33.24% and a negative return on equity of 9.21%. The firm's revenue for the quarter was down 55.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.10 earnings per share. View Applied Genetic Technologies' Earnings History.

When will Applied Genetic Technologies make its next earnings announcement?

Applied Genetic Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, May, 9th 2018. View Earnings Estimates for Applied Genetic Technologies.

Where is Applied Genetic Technologies' stock going? Where will Applied Genetic Technologies' stock price be in 2018?

6 analysts have issued 1-year price objectives for Applied Genetic Technologies' stock. Their predictions range from $7.00 to $16.00. On average, they anticipate Applied Genetic Technologies' stock price to reach $10.17 in the next twelve months. View Analyst Ratings for Applied Genetic Technologies.

What are Wall Street analysts saying about Applied Genetic Technologies stock?

Here are some recent quotes from research analysts about Applied Genetic Technologies stock:

  • 1. According to Zacks Investment Research, "Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida. " (1/9/2018)
  • 2. Cantor Fitzgerald analysts commented, "Natural history data from imaging 41 patients with CNGB3-associated achromatopsia (ACHM B3) between 6 and 26 months was published in the journel Retina journal today, suggest functional endpoints for evaluating efficacy." (10/6/2017)
  • 3. Rodman & Renshaw analysts commented, "A leader in AAV development; first-in-man data soon and critical to investment case. AGTC's AAV (adeno-associated virus) platform is based on a proprietary viral composition and manufacturing process that are backed by strong intellectual property positions. AGTC has the capability to target specific tissue types and drive gene expression appropriate for that tissue. We believe that there is great potential to treat an array of disorders that are monogenic (single gene) and autosomal recessive or X-linked. The company is currently targeting orphan ophthalmological indications with the goal of addressing the underlying biology of the disorder.Plenty of cash to fund development. We believe the preclinical data in hand support our projected outcome for positive results from the ongoing clinical programs. We are quickly approaching critical first-in-man data in mid-2017 from the company's lead program in XLRS and initial clinical data from the ACHM program by year-end 2017. We believe these data should help correct the valuation disconnect we call to investors' attention where the stock is trading below the company's cash balance, primarily due to the early stage nature of the platform. Additionally, the company has approximately two years of cash on hand to deliver to our development projections; furthermore, the trajectory should create inflection points that include the clinical data points mentioned as well as advancing more products into development." (3/15/2017)

Who are some of Applied Genetic Technologies' key competitors?

Who are Applied Genetic Technologies' key executives?

Applied Genetic Technologies' management team includes the folowing people:

  • Scott Koenig M.D., Ph.D., Chairman of the Board (Age 64)
  • Susan B. Washer, President, Chief Executive Officer, Director (Age 55)
  • William A. Sullivan, Chief Financial Officer (Age 46)
  • Jeffrey D. Chulay M.D., Senior Vice President, Chief Medical Officer (Age 70)
  • Mark Shearman Ph.D., Chief Scientific Officer (Age 55)
  • Stephen B. Potter, Vice president and chief business officer (Age 60)
  • Andrew D. Ashe, General Counsel (Age 49)
  • Michael H. Goldstein M.D., Chief Medical Officer (Age 50)
  • Ivana Magovcevic-Liebisch Ph.D. J.D., Director (Age 49)
  • Anne M. VanLent, Director (Age 68)

Who owns Applied Genetic Technologies stock?

Applied Genetic Technologies' stock is owned by a number of of retail and institutional investors. Top institutional investors include Acadian Asset Management LLC (3.75%), BlackRock Inc. (2.55%), Renaissance Technologies LLC (2.46%), Municipal Employees Retirement System of Michigan (1.72%), 683 Capital Management LLC (1.19%) and Millennium Management LLC (0.62%). Company insiders that own Applied Genetic Technologies stock include Ivana Magovcevic, Jeffrey D Chulay, Lawrence E Bullock, Mark S Shearman and Stephen W Potter. View Institutional Ownership Trends for Applied Genetic Technologies.

Who sold Applied Genetic Technologies stock? Who is selling Applied Genetic Technologies stock?

Applied Genetic Technologies' stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, BlackRock Inc., Deutsche Bank AG and Acadian Asset Management LLC. View Insider Buying and Selling for Applied Genetic Technologies.

Who bought Applied Genetic Technologies stock? Who is buying Applied Genetic Technologies stock?

Applied Genetic Technologies' stock was acquired by a variety of institutional investors in the last quarter, including 683 Capital Management LLC, Municipal Employees Retirement System of Michigan, Renaissance Technologies LLC, Spark Investment Management LLC and Two Sigma Investments LP. Company insiders that have bought Applied Genetic Technologies stock in the last two years include Ivana Magovcevic, Lawrence E Bullock, Mark S Shearman and Stephen W Potter. View Insider Buying and Selling for Applied Genetic Technologies.

How do I buy Applied Genetic Technologies stock?

Shares of Applied Genetic Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Applied Genetic Technologies' stock price today?

One share of Applied Genetic Technologies stock can currently be purchased for approximately $3.75.

How big of a company is Applied Genetic Technologies?

Applied Genetic Technologies has a market capitalization of $67.89 million and generates $39.47 million in revenue each year. The biotechnology company earns $400,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. Applied Genetic Technologies employs 72 workers across the globe.

How can I contact Applied Genetic Technologies?

Applied Genetic Technologies' mailing address is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. The biotechnology company can be reached via phone at 386-462-2204.


MarketBeat Community Rating for Applied Genetic Technologies (AGTC)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  247 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about Applied Genetic Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Applied Genetic Technologies (NASDAQ:AGTC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.832.67
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.17$10.17$10.17$14.63
Price Target Upside: 164.07% upside157.38% upside178.54% upside192.50% upside

Applied Genetic Technologies (NASDAQ:AGTC) Consensus Price Target History

Price Target History for Applied Genetic Technologies (NASDAQ:AGTC)

Applied Genetic Technologies (NASDAQ:AGTC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2018WedbushReiterated RatingOutperformHighView Rating Details
2/9/2018HC WainwrightSet Price TargetBuy$8.00LowView Rating Details
1/17/2018Cantor FitzgeraldReiterated RatingHold$9.00LowView Rating Details
9/14/2017BMO Capital MarketsReiterated RatingOutperform$14.00 -> $7.00HighView Rating Details
9/14/2017Stifel NicolausLower Price TargetBuy -> Buy$15.00 -> $12.00HighView Rating Details
3/15/2017Rodman & RenshawInitiated CoverageBuy -> Buy$16.00HighView Rating Details
11/9/2016Roth CapitalUpgradeNeutral -> Buy$12.00 -> $15.00N/AView Rating Details
9/26/2016Janney Montgomery ScottUpgradeSell -> Neutral$11.00N/AView Rating Details
9/13/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Applied Genetic Technologies (NASDAQ:AGTC) Earnings History and Estimates Chart

Earnings by Quarter for Applied Genetic Technologies (NASDAQ:AGTC)

Applied Genetic Technologies (NASDAQ AGTC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018        
2/9/2018Q2 2018($0.09)($0.29)$8.72 million$4.85 millionViewListenView Earnings Details
11/7/2017Q1 2018($0.14)($0.08)$8.62 million$10.32 millionViewN/AView Earnings Details
9/13/2017Q4 2017$0.22($0.18)$12.39 million$8.30 millionViewN/AView Earnings Details
5/10/2017Q3 2017($0.01)($0.05)$10.39 million$8.39 millionViewN/AView Earnings Details
2/8/2017Q217$0.02$0.11$11.10 million$10.90 millionViewListenView Earnings Details
11/8/2016Q117($0.10)$0.20$10.21 million$11.80 millionViewListenView Earnings Details
9/12/2016Q416$0.07$0.15$13.10 million$12.10 millionViewListenView Earnings Details
5/9/2016Q3$0.05$0.11$12.98 million$12.00 millionViewN/AView Earnings Details
2/8/2016Q216($0.19)$0.17$8.76 million$12.20 millionViewN/AView Earnings Details
11/5/2015Q1($0.20)($0.53)$5.91 million$11.06 millionViewN/AView Earnings Details
9/10/2015Q415($0.41)($0.48)$0.63 million$0.71 millionViewN/AView Earnings Details
5/11/2015Q315($0.33)($0.38)$0.59 million$0.28 millionViewN/AView Earnings Details
2/11/2015Q215($0.39)($0.28)$0.45 million$0.65 millionViewN/AView Earnings Details
11/12/2014Q115($0.29)($0.34)$258.00 million$705.00 millionViewN/AView Earnings Details
9/26/2014Q414($0.29)($0.32)$0.23 million$0.12 millionViewN/AView Earnings Details
5/14/2014Q114($0.37)($25.45)$0.15 million$0.23 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Applied Genetic Technologies (NASDAQ:AGTC) Earnings Estimates

2018 EPS Consensus Estimate: ($1.29)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.18)($0.18)($0.18)
Q2 20181($0.01)($0.01)($0.01)
Q3 20181($0.37)($0.37)($0.37)
Q4 20181($0.73)($0.73)($0.73)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Applied Genetic Technologies (NASDAQ:AGTC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Applied Genetic Technologies (NASDAQ AGTC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 45.99%
Insider Trades by Quarter for Applied Genetic Technologies (NASDAQ:AGTC)
Insider Trades by Quarter for Applied Genetic Technologies (NASDAQ:AGTC)

Applied Genetic Technologies (NASDAQ AGTC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2016Ivana MagovcevicDirectorBuy3,000$9.63$28,890.003,000View SEC Filing  
11/1/2016Jeffrey D ChulayVPSell1,000$7.05$7,050.0020,400View SEC Filing  
9/22/2016Mark S ShearmanInsiderBuy3,000$8.87$26,610.001,700View SEC Filing  
9/20/2016Stephen W PotterInsiderBuy1,400$8.89$12,446.001,000View SEC Filing  
9/19/2016Lawrence E BullockCFOBuy10,000$8.75$87,500.0010,000View SEC Filing  
2/23/2015Plc GlaxosmithklineMajor ShareholderSell503,150$22.00$11,069,300.00View SEC Filing  
1/23/2015Daniel L MenichellaVPSell1,996$24.90$49,700.40View SEC Filing  
12/22/2014Daniel L MenichellaVPSell9,000$20.83$187,470.00View SEC Filing  
4/1/2014Interwest Partners Viii LpMajor ShareholderBuy75,376$12.00$904,512.00View SEC Filing  
4/1/2014Jill CarrollDirectorBuy103,762$12.00$1,245,144.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Applied Genetic Technologies (NASDAQ AGTC) News Headlines

Source:
DateHeadline
Applied Genetic Technologies (AGTC) Earns Outperform Rating from WedbushApplied Genetic Technologies (AGTC) Earns Outperform Rating from Wedbush
www.americanbankingnews.com - February 18 at 9:50 PM
AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of DirectorsAGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors
finance.yahoo.com - February 15 at 9:16 AM
FY2018 Earnings Forecast for Applied Genetic Technologies Corp (AGTC) Issued By Cantor FitzgeraldFY2018 Earnings Forecast for Applied Genetic Technologies Corp (AGTC) Issued By Cantor Fitzgerald
www.americanbankingnews.com - February 14 at 11:38 AM
Wired News – Catalyst Biosciences Shares Positive Top-line Data from Phase-1/2 Study of Subcutaneous CB 2679d for Hemophilia BWired News – Catalyst Biosciences Shares Positive Top-line Data from Phase-1/2 Study of Subcutaneous CB 2679d for Hemophilia B
finance.yahoo.com - February 12 at 9:07 AM
Applied Genetic Technologies Corp (AGTC) Receives Average Recommendation of "Hold" from BrokeragesApplied Genetic Technologies Corp (AGTC) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - February 10 at 9:44 AM
 Analysts Anticipate Applied Genetic Technologies Corp (AGTC) Will Announce Quarterly Sales of $10.92 Million Analysts Anticipate Applied Genetic Technologies Corp (AGTC) Will Announce Quarterly Sales of $10.92 Million
www.americanbankingnews.com - February 10 at 2:48 AM
Applied Genetic Technologies (AGTC) PT Set at $8.00 by HC WainwrightApplied Genetic Technologies (AGTC) PT Set at $8.00 by HC Wainwright
www.americanbankingnews.com - February 9 at 4:10 PM
Applied Genetic Technologies (AGTC) Releases  Earnings Results, Misses Estimates By $0.20 EPSApplied Genetic Technologies (AGTC) Releases Earnings Results, Misses Estimates By $0.20 EPS
www.americanbankingnews.com - February 9 at 10:26 AM
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017
finance.yahoo.com - February 9 at 9:13 AM
Applied Genetic Technologies Corp. to Host Earnings CallApplied Genetic Technologies Corp. to Host Earnings Call
finance.yahoo.com - February 9 at 9:13 AM
Applied Genetic Technologies posts 2Q lossApplied Genetic Technologies posts 2Q loss
finance.yahoo.com - February 9 at 9:13 AM
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 9, 2018AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 9, 2018
finance.yahoo.com - February 2 at 8:44 AM
Applied Genetic Technologies (AGTC) to Release Quarterly Earnings on TuesdayApplied Genetic Technologies (AGTC) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - January 30 at 2:56 AM
$10.92 Million in Sales Expected for Applied Genetic Technologies Corp (AGTC) This Quarter$10.92 Million in Sales Expected for Applied Genetic Technologies Corp (AGTC) This Quarter
www.americanbankingnews.com - January 24 at 2:58 AM
Cantor Fitzgerald Reaffirms Hold Rating for Applied Genetic Technologies (AGTC)Cantor Fitzgerald Reaffirms Hold Rating for Applied Genetic Technologies (AGTC)
www.americanbankingnews.com - January 18 at 1:50 PM
Applied Genetic Technologies Corp (AGTC) Given Average Rating of "Hold" by AnalystsApplied Genetic Technologies Corp (AGTC) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - January 16 at 10:32 AM
Zacks: Analysts Expect Applied Genetic Technologies Corporation (AGTC) Will Post Quarterly Sales of $10.92 MillionZacks: Analysts Expect Applied Genetic Technologies Corporation (AGTC) Will Post Quarterly Sales of $10.92 Million
www.americanbankingnews.com - January 7 at 6:38 AM
Zacks: Analysts Expect Applied Genetic Technologies Corporation (AGTC) Will Post Earnings of -$0.09 Per ShareZacks: Analysts Expect Applied Genetic Technologies Corporation (AGTC) Will Post Earnings of -$0.09 Per Share
www.americanbankingnews.com - January 5 at 5:32 PM
Analysts Issue Forecasts for Applied Genetic Technologies Corporations FY2019 Earnings (AGTC)Analysts Issue Forecasts for Applied Genetic Technologies Corporation's FY2019 Earnings (AGTC)
www.americanbankingnews.com - January 4 at 11:40 PM
ETFs with exposure to Applied Genetic Technologies Corp. : December 25, 2017ETFs with exposure to Applied Genetic Technologies Corp. : December 25, 2017
finance.yahoo.com - December 25 at 4:14 PM
Zacks: Brokerages Anticipate Applied Genetic Technologies Corporation (AGTC) Will Post Quarterly Sales of $10.92 MillionZacks: Brokerages Anticipate Applied Genetic Technologies Corporation (AGTC) Will Post Quarterly Sales of $10.92 Million
www.americanbankingnews.com - December 22 at 9:20 PM
Applied Genetic Technologies Corporation (AGTC) Given Average Recommendation of "Hold" by AnalystsApplied Genetic Technologies Corporation (AGTC) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - December 22 at 10:28 AM
-$0.09 EPS Expected for Applied Genetic Technologies Corporation (AGTC) This Quarter-$0.09 EPS Expected for Applied Genetic Technologies Corporation (AGTC) This Quarter
www.americanbankingnews.com - December 20 at 5:14 AM
ETFs with exposure to Applied Genetic Technologies Corp. : December 12, 2017ETFs with exposure to Applied Genetic Technologies Corp. : December 12, 2017
finance.yahoo.com - December 12 at 3:37 PM
AGTC to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference on December 14, 2017 - GlobeNewswire (press release)AGTC to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference on December 14, 2017 - GlobeNewswire (press release)
globenewswire.com - December 12 at 11:56 AM
AGTC to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference on December 14, 2017AGTC to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference on December 14, 2017
feeds.benzinga.com - December 11 at 4:49 PM
$10.92 Million in Sales Expected for Applied Genetic Technologies Corporation (AGTC) This Quarter$10.92 Million in Sales Expected for Applied Genetic Technologies Corporation (AGTC) This Quarter
www.americanbankingnews.com - December 4 at 11:02 AM
ETFs with exposure to Applied Genetic Technologies Corp. : December 1, 2017ETFs with exposure to Applied Genetic Technologies Corp. : December 1, 2017
finance.yahoo.com - December 1 at 4:30 PM
Applied Genetic Technologies Corporation (AGTC) Given Consensus Recommendation of "Hold" by BrokeragesApplied Genetic Technologies Corporation (AGTC) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 27 at 2:00 PM
ETFs with exposure to Applied Genetic Technologies Corp. : November 20, 2017ETFs with exposure to Applied Genetic Technologies Corp. : November 20, 2017
finance.yahoo.com - November 20 at 5:07 PM
Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 15, 2017Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 15, 2017
finance.yahoo.com - November 16 at 10:52 AM
-$0.09 Earnings Per Share Expected for Applied Genetic Technologies Corporation (AGTC) This Quarter-$0.09 Earnings Per Share Expected for Applied Genetic Technologies Corporation (AGTC) This Quarter
www.americanbankingnews.com - November 14 at 1:28 AM
Brokers Set Expectations for Applied Genetic Technologies Corporations Q3 2018 Earnings (AGTC)Brokers Set Expectations for Applied Genetic Technologies Corporation's Q3 2018 Earnings (AGTC)
www.americanbankingnews.com - November 13 at 7:54 AM
Applied Genetic Technologies Corporation (AGTC) & Its Competitors Critical ComparisonApplied Genetic Technologies Corporation (AGTC) & Its Competitors Critical Comparison
www.americanbankingnews.com - November 11 at 5:28 AM
Q2 2018 EPS Estimates for Applied Genetic Technologies Corporation Decreased by Analyst (AGTC)Q2 2018 EPS Estimates for Applied Genetic Technologies Corporation Decreased by Analyst (AGTC)
www.americanbankingnews.com - November 10 at 11:54 AM
ETFs with exposure to Applied Genetic Technologies Corp. : November 9, 2017ETFs with exposure to Applied Genetic Technologies Corp. : November 9, 2017
finance.yahoo.com - November 9 at 4:40 PM
Applied Genetic Technologies Corporations (AGTC) Buy Rating Reiterated at HC WainwrightApplied Genetic Technologies Corporation's (AGTC) Buy Rating Reiterated at HC Wainwright
www.americanbankingnews.com - November 8 at 11:10 PM
Edited Transcript of AGTC earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of AGTC earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 5:49 PM
Applied Genetic Technologies Corporation (AGTC) Stock Rating Reaffirmed by WedbushApplied Genetic Technologies Corporation (AGTC) Stock Rating Reaffirmed by Wedbush
www.americanbankingnews.com - November 8 at 3:40 PM
Applied Genetic Technologies (AGTC) CEO Sue Washer on Q1 2018 Results - Earnings Call Transcript - Seeking AlphaApplied Genetic Technologies' (AGTC) CEO Sue Washer on Q1 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 8 at 3:19 AM
Applied Genetic Technologies Corporation (AGTC) Posts Quarterly  Earnings Results, Beats Estimates By $0.06 EPSApplied Genetic Technologies Corporation (AGTC) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS
www.americanbankingnews.com - November 8 at 12:22 AM
Applied Genetic Technologies posts 1Q lossApplied Genetic Technologies posts 1Q loss
finance.yahoo.com - November 7 at 10:18 PM
Is Applied Genetic Technologies Corporation (AGTC) A Sell At Its Current Price?Is Applied Genetic Technologies Corporation (AGTC) A Sell At Its Current Price?
finance.yahoo.com - November 7 at 10:18 PM
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017 - GlobeNewswire (press release)AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017 - GlobeNewswire (press release)
globenewswire.com - November 7 at 5:15 PM
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017
finance.yahoo.com - November 7 at 5:14 PM
Applied Genetic Technologies Corporation (AGTC) Receives Average Recommendation of "Hold" from BrokeragesApplied Genetic Technologies Corporation (AGTC) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 2 at 12:02 PM
Applied Genetic Technologies Corporation (AGTC) Set to Announce Quarterly Earnings on TuesdayApplied Genetic Technologies Corporation (AGTC) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - November 1 at 10:58 AM
Applied Genetic Technologies Corporation (AGTC) Cut to Strong Sell at Zacks Investment ResearchApplied Genetic Technologies Corporation (AGTC) Cut to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - October 31 at 5:32 PM
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017 - GlobeNewswire (press release)AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017 - GlobeNewswire (press release)
globenewswire.com - October 31 at 4:52 PM
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017 - GlobeNewswire (press release)AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017 - GlobeNewswire (press release)
globenewswire.com - October 31 at 4:52 PM

SEC Filings

Applied Genetic Technologies (NASDAQ:AGTC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Applied Genetic Technologies (NASDAQ:AGTC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Applied Genetic Technologies (NASDAQ AGTC) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.